Arch Biopartners Inc. (ACHFF)
OTCMKTS · Delayed Price · Currency is USD
1.340
+0.007 (0.53%)
Jun 6, 2025, 11:48 AM EDT

Arch Biopartners Cash Flow Statement

Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2015 - 2019
Net Income
-3.03-3.92-3.33-1.41-1.17-4.63
Upgrade
Other Operating Activities
0.281.593.091.89-1.812.72
Upgrade
Operating Cash Flow
-2.75-2.33-0.230.48-2.98-1.9
Upgrade
Long-Term Debt Issued
-0.351.5-2.20.5
Upgrade
Long-Term Debt Repaid
--0.21-1.07-0.79-0.47-0.01
Upgrade
Net Debt Issued (Repaid)
0.60.140.43-0.791.730.49
Upgrade
Issuance of Common Stock
2.151.360.130.371.051.67
Upgrade
Financing Cash Flow
2.751.50.56-0.422.782.16
Upgrade
Net Cash Flow
0-0.830.320.06-0.210.25
Upgrade
Cash Interest Paid
0000.080.07-
Upgrade
Levered Free Cash Flow
-1.58-1.290.680.61-2.54-0.14
Upgrade
Unlevered Free Cash Flow
-1.36-1.050.910.8-2.37-0.03
Upgrade
Change in Net Working Capital
-0.08-0.26-0.76-1.41.96-0.98
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.